2007, Comprehensive Analysis of Pharmaceutical Development Trends [Vol. 4. Foreign Capital Companies]
Outline of the report
As rapid progress has been made in the implementation of reorganization programs in the pharmaceutical industry in Japan over the past year, with a total of 28 foreign-capital companies having merged into 15 during the past decade. Seed Plannings serial publication '2007, Comprehensive Analysis of Pharmaceutical Development Trends <Vol. 4. Foreign Capital Companies> 'provides detailed analysis of annual sales, individual companys policies on research & development, production, and distribution, organizational structure, and the background of mergers. With this book, you can obtain updates on the current status and future trends of foreign-capital pharmaceutical companies that are facing global streamlining programs including the closure, integration and spin-off of production plants and R&D centers.
| Title of the report | 2007, Comprehensive Analysis of Pharmaceutical Development Trends [Vol. 4. Foreign Capital Companies] |
| Date of issue | 31/07/07 |
| Volume | A4 / 471 pages |
| Price | 95,000JPY |
| Produced by | Seed Planning, Inc. |
| Note | This report is written in Japanese. Customers who need an English version:Please contact us. |
| Category | Pharmaceutical products / compaines |
Details of the report
Objectives of the study
- [Japanese arms of foreign-capital companies]
-
- Company overview
- Financial Data (Sales / Profit / Number of employees / R&D cost / R&D headcount)
- Pharmaceuticals sales (Sales by indication / Top 5 products)
- Structural / association charts
- Business trends
- R&D strategies (Concept / organizational flow chart / R&D centers / partnership)
- Sales and marketing approaches and distribution system
- Investigational drugs
- List of ethical drugs approved
- Individual data for investigational drugs
- [Parent companies]
-
- Company overview
- Business trends
- Financial data
- Financial data by region
- Sales of major products
- R&D pipeline
- R&D partnership
- R&D centers worldwide